CXCL9 - Wikipedia
Chemokine (C-X-C motif) ligand 9 (CXCL9) is a small cytokine belonging to the CXC chemokine family that is also known as monokine induced by gamma interferon (MIG). The CXCL9 is one …
Science｜CXCL9:SPP1巨噬细胞极性确定是肿瘤微环境的一个简单 …
2023年8月16日 · 他们的最新研究“CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers”已于著名期刊《Science》上发表。作者发现， …
CXCL9 (CXC 趋化因子配体 9) - MCE-生物活性分子大师
cxcl9 是趋化因子受体 cxcr3 的配体之一，可介导淋巴细胞浸润到病灶部位并抑制肿瘤生长。 CXCL9 吸引 CXCR3-(CXCR3-A 和 CXCR3-B) T 淋巴细胞，参与多种生理疾病在其起始和维持 …
CXCL9 - 维基百科，自由的百科全书
CXCL9（英語： Chemokine (C-X-C motif) ligand 9 ）是一小分子的细胞因子属于CXC趋化因子家族，又被称作“干扰素伽玛诱导的单核细胞因子”（Monokine induced by gamma interferon, …
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a …
CXCL9, also known as monokine induced by gamma interferon (MIG), is located on human chromosome 4, and is induced by IFN-γ but not by IFN-α/β. CXCL10 and CXCL11 are also …
CXCL9 Gene - GeneCards | CXCL9 Protein | CXCL9 Antibody
2025年3月30日 · CXCL9 (C-X-C Motif Chemokine Ligand 9) is a Protein Coding gene. Diseases associated with CXCL9 include Proliferative Glomerulonephritis and Paracoccidioidomycosis. …
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - PubMed
The CXCL9, -10, -11/CXCR3 axis regulates immune cell migration, differentiation, and activation, leading to tumor suppression (paracrine axis). However, there are some reports that show …
The role of CXCL family members in different diseases
2023年7月1日 · CXCL9 participates in metabolic-associated fatty liver disease via facilitating the imbalance of Treg/Th17 cells with interferon-gamma, providing another new direction to treat …
CXCL9在乳腺癌中的表达及其与肿瘤免疫浸润特征的相关性研究
目的·探究C-X-C模体趋化因子配体9（C-X-C motif chemokine ligand 9，CXCL9）表达对乳腺癌患者预后的影响及其与肿瘤浸润免疫细胞（tumor-infiltrating immune cell，TIIC）的相关性。 方 …
CXCL9 C-X-C motif chemokine ligand 9 [ Homo sapiens (human) ]
2025年3月8日 · Title: CXCL9 may serve as a potential biomarker for primary Sjögren's syndrome with extra-glandular manifestations. Deciphering tumor microenvironment: CXCL9 and SPP1 …